+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Onychomycosis Treatment Market: By type, and distribution channel - Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

  • ID: 5143438
  • Report
  • November 2019
  • Region: Global
  • 130 pages
  • Zion Market Research
The report covers forecast and analysis for the Onychomycosis Treatment market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Onychomycosis Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Onychomycosis Treatment market on a global level. In order to give the users of this report a comprehensive view on the Onychomycosis Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein type, treatment, distribution channel, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

Onychomycosis, also known as tinea unguium, is a toenail or fingernail fungal disease that causes infection of the ring over the nails. Trichophyton rubrum and trichophyton mentagrophytes are common fungal strains that cause dermatophytic onychomycosis. In addition, other organisms that transmit the disease are yeasts and non-dermatophyte molds. The major source of onychomycosis is public places such as gymnasium, swimming pool, and others polluted with disease causing fungal agents. In addition, fungal infection is caused by continuous use of footwear for a longer duration and touch of toe nail with wet surface. Increasing disease incidences are apparent in athletes due to constant shoe use, nail sweating, and traumatic nail injuries.

The study provides a decisive view on the Onychomycosis Treatment market by segmenting the market based on type, treatment, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on type, the market is segmented into distal sublingual onychomycosis, white superficial onychomycosis, proximal sublingual onychomycosis, candida onychomycosis and others. The study projects that the prevalence of proximal subungal onychomycosis will increase at a significant rate in the coming years, while distal subungal onychomycosis is the most prevalent disease indication driving the demand for care.

Based on treatment, the market is segmented into drug treatment, topical therapy and others. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries such as US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. North America is expected to dominate the market owing to the presence of important market companies, sophisticated healthcare infrastructure and an alarming upsurge in the diabetic patient pool.

Both pediatrists and dermatologists cited bolstering recommendations for combination therapy as another strong factor promoting the worldwide demand for onychomycosis treatment. Research shows an increased rate of cure when the therapy blends systemic and topical treatments, which possibly encourages onychomycosis patients to opt for care requiring medication for long-term antifungal drugs, accompanied by the use of nail lacquers. Oral terbinafine has been a popular choice over the years to include in combination therapy, followed in follow-up sessions by amorolfine nail lacquer. As part of onychomycosis treatment, the advent of more such combination therapies is likely to support the development of the demand for onychomycosis treatment in the coming years.

Key players within global Onychomycosis Treatment market include Bausch Health Companies, Galderma S.A., Celtic Pharma, Anacor pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., GlaxoSmithKline, Topica Pharmaceuticals, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd, Allergen, Inc., Cipla Ltd, Medimetriks Pharmaceuticals Inc., Sanofi S.A., NovaBiotics Inc., and Merz Pharma. amongst others.

The report segments global Onychomycosis Treatment market as follows:

Global Onychomycosis Treatment Market: Type Segment Analysis
  • Distal sublingual Onychomycosis
  • White superficial Onychomycosis
  • Proximal sublingual Onychomycosis
  • Candida Onychomycosis
  • Others
Global Onychomycosis Treatment Market: Treatment Segment Analysis
  • Drug Treatment
  • Topical Therapy
  • Others
Global Onychomycosis Treatment Market: Distribution Channel Segment Analysis
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Global Onychomycosis Treatment Market: Regional Segment Analysis
  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Onychomycosis Treatment Market, 2016-2025 (USD Million)
    • 2.2. Onychomycosis Treatment Market: Snapshot
  • Chapter 3. Onychomycosis Treatment Market - Industry Analysis
    • 3.1. Onychomycosis Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By Treatment
      • 3.6.3. Market attractiveness analysis By Distribution Channel
      • 3.6.4. Market attractiveness analysis By Region
  • Chapter 4. Onychomycosis Treatment Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Onychomycosis Treatment Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Onychomycosis Treatment Market -Product Analysis
    • 5.1. Global Onychomycosis Treatment Market overview: By Type
      • 5.1.1. Global Onychomycosis Treatment Market share, By Product,2018 and 2025
    • 5.2. Distal sublingual Onychomycosis
      • 5.2.1. Global Onychomycosis Treatment Market By Distal sublingual Onychomycosis, 2016-2025 (USD Million)
    • 5.3. White superficial Onychomycosis
      • 5.3.1. Global Onychomycosis Treatment Market By White superficial Onychomycosis, 2016-2025 (USD Million)
    • 5.4. Proximal sublingual Onychomycosis
      • 5.4.1. Global Onychomycosis Treatment Market By Proximal sublingual Onychomycosis, 2016-2025 (USD Million)
    • 5.5. Candida Onychomycosis
      • 5.5.1. Global Onychomycosis Treatment Market By Candida Onychomycosis, 2016-2025 (USD Million)
    • 5.6. Others
      • 5.6.1. Global Onychomycosis Treatment Market By others, 2016-2025 (USD Million)
  • Chapter 6. Global Onychomycosis Treatment Market -Treatment Analysis
    • 6.1. Global Onychomycosis Treatment Market overview: By Treatment
      • 6.1.1. Global Onychomycosis Treatment Market share, By Treatment, 2018 and 2025
    • 6.2. Drug Treatment
      • 6.2.1. Global Onychomycosis Treatment Market By Drug Treatment, 2016-2025 (USD Million)
    • 6.3. Topical Therapy
      • 6.3.1. Global Onychomycosis Treatment Market By Topical Therapy, 2016-2025 (USD Million)
    • 6.4. Others
      • 6.4.1. Global Onychomycosis Treatment Market By Other Treatments, 2016-2025 (USD Million)
  • Chapter 7. Global Onychomycosis Treatment Market -Distribution Channel Analysis
    • 7.1. Global Onychomycosis Treatment Market overview: By Distribution Channel
      • 7.1.1. Global Onychomycosis Treatment Market share, By Distribution Channel, 2018 and 2025
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Onychomycosis Treatment Market By Hospital Pharmacies, 2016-2025 (USD Million)
    • 7.3. Retail Pharmacies
      • 7.3.1. Global Onychomycosis Treatment Market By Retail Pharmacies, 2016-2025 (USD Million)
    • 7.4. Others
      • 7.4.1. Global Onychomycosis Treatment Market By others, 2016-2025 (USD Million)
  • Chapter 8. Global Onychomycosis Treatment Market - Regional Analysis
    • 8.1. Global Onychomycosis Treatment Market overview: By Region
      • 8.1.1. Global Onychomycosis Treatment Market share, By Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Onychomycosis Treatment Market, 2016-2025 (USD Million)
      • 8.2.2. North America Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
      • 8.2.3. North America Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
      • 8.2.4. North America Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S.Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.5.2. The U.S.Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S.Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. EuropeOnychomycosis Treatment Market 2016-2025 (USD Million)
      • 8.3.2. Europe Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
      • 8.3.3. Europe Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
      • 8.3.4. Europe Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. U.K.Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.5.2. U.K.Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.3.5.3. U.K. Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.6.2. France Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.3.6.3. France Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.7.2. Germany Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.3.7.3. Germany Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of EuropeOnychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.8.2. Rest of EuropeOnychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Onychomycosis Treatment Market, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.5.2. China Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.4.5.3. China Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.6.2. Japan Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.4.6.3. Japan Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.7.2. India Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.4.7.3. India Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Onychomycosis Treatment Market, 2016-2025 (USD Million)
      • 8.5.2. Latin America Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
      • 8.5.3. Latin America Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
      • 8.5.4. Latin America Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.5.5.2. Brazil Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
        • 8.5.6.2. Rest of Latin America Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Onychomycosis Treatment Market, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Onychomycosis Treatment Market revenue, By Product,2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Onychomycosis Treatment Market revenue, By Treatment, 2016-2025 (USD Million)
      • 8.6.4. The Middle East and Africa Onychomycosis Treatment Market revenue, By Distribution Channel, 2016-2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Bausch Health Companies
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Galderma S.A
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Celtic Pharma
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Anacor pharmaceuticals, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Johnson & Johnson
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Novartis AG, Pfizer Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. GlaxoSmithKline
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Topica Pharmaceuticals, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Moberg Pharma AB
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. Bayer AG
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development
Note: Product cover images may vary from those shown
Adroll
adroll